🌍 **Papilocare International Scientific Conference - A Resounding Success!** 🌟 March 7th, 2024, Barcelona 🇪🇸
We're thrilled to announce that Procare Health has successfully organized a landmark international scientific conference, uniting over 300 leading gynecologists specializing in onco-gynecology and HPV management. This event marked a pivotal moment in the global fight against HPV, under the esteemed chairmanship of Professor Jordi Ponce (Head of Gynecology at Belvitge Hospital and President of the Barcelona’s ESGO Congress) and Professor Murat Gultekin (Chairman of the HPV Prevention Committee of the ESGO Society).
The conference showcased enlightening scientific speeches, including:
- **Dr. Kathrine Lycke** (Kvindesygdomme og Fødsler, RHG, Denmark ) on "A Decade's Perspective in Conservative Management of CIN2: A Large Danish Cohort's Experience"
- **Dr. Maria Kyrgiou** from Imperial College London on "The Influential Role of Microbiome in the Progression and Regression of HPV-Dependent Lesions"
- **Dr. Damian Dexeus** (Medical Director of Women’s CD, Barcelona, Spain) on "Beyond Active Surveillance of HPV Dependent Lesions: Exploring New Frontiers"
We're proud to contribute to the pivotal scientific research on HPV and to the advancement of academic education that challenges and evolves the current paradigms of HPV management.
**Exciting News**: Papilocare is now available in over 50 countries, thanks to our collaborations with first-class pharmaceutical companies worldwide, including Gedeon Richter, Besins Healthcare, Megalab, Oktal, Elpen, Dr. Pfleger, River Pharma, Procaps, and more. This achievement reflects our commitment to excellence and our mission to make a global impact.
Let's continue to break barriers and shape the future of HPV and healthcare together. 💪 #PapilocareConference2024 #HPVManagement #GlobalHealthImpact #ScienceForABetterTomorrow
#papilocare
@procarehealthiberia